Related Experiment Videos
Effects of injected deposteroid on posttonsillectomy morbidity: a double-blind study
Archives of Otolaryngology (Chicago, Ill. : 1960)
|February 1, 1975
Summary
Methylprednisolone acetate injections reduced post-tonsillectomy pain. However, this steroid treatment did not significantly improve swallowing, diet resumption, or healing rates in patients undergoing tonsillectomy.
Area of Science:
- Otolaryngology
- Surgical Recovery
- Pharmacology
Background:
- Post-tonsillectomy morbidity significantly impacts patient recovery.
- Various agents have been studied to alleviate tonsillectomy complications.
- Conclusive evidence for effective treatments remains limited.
Purpose of the Study:
- To evaluate the efficacy of methylprednisolone acetate (Depo-Medrol) in reducing post-tonsillectomy morbidity.
- To assess the impact of deposteroid injections on pain, swallowing, diet, and healing.
Main Methods:
- A double-blind, randomized study involving 165 patients.
- Patients were divided into two groups: deposteroid (methylprednisolone acetate) and control (normal saline).
- 2.5 ml of the assigned solution was injected into each tonsillar fossa post-surgery.
Main Results:
- The deposteroid group experienced reduced postoperative pain compared to the control group.
- No significant differences were observed in difficulty swallowing or diet resumption.
- The rate of tonsillar fossa healing was not significantly altered by the deposteroid treatment.
Conclusions:
- Methylprednisolone acetate injections can effectively reduce immediate post-tonsillectomy pain.
- Deposteroid treatment does not appear to significantly improve other key aspects of post-tonsillectomy recovery, such as swallowing function or healing.
- Further research may be needed to explore alternative or adjunctive treatments for comprehensive post-tonsillectomy morbidity reduction.